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Abstract
Amyloid PET imaging is an indispensable tool widely used in the investigation, diagnosis
and monitoring of Alzheimer’s disease (AD). Currently, a reference region based approach
is used as the mainstream quantification technique for amyloid imaging. This approach as-
sumes the reference region is amyloid free and has the same tracer influx and washout ki-
netics as the regions of interest. However, this assumption may not always be valid. The
goal of this work is to evaluate an amyloid imaging quantification technique that uses arterial
region of interest as the reference to avoid potential bias caused by specific binding in the
reference region. 21 participants, age 58 and up, underwent Pittsburgh compound B (PiB)
PET imaging and MR imaging including a time-of-flight (TOF) MR angiography (MRA) scan
and a structural scan. FreeSurfer based regional analysis was performed to quantify PiB
PET data. Arterial input function was estimated based on coregistered TOF MRA using
a modeling based technique. Regional distribution volume (VT) was calculated using
Logan graphical analysis with estimated arterial input function. Kinetic modeling was also
performed using the estimated arterial input function as a way to evaluate PiB binding
(DVRkinetic) without a reference region. As a comparison, Logan graphical analysis was also
performed with cerebellar cortex as reference to obtain DVRREF. Excellent agreement was
observed between the two distribution volume ratio measurements (r>0.89, ICC>0.80).
The estimated cerebellum VT was in line with literature reported values and the variability of
cerebellum VT in the control group was comparable to reported variability using arterial sam-
pling data. This study suggests that image-based arterial input function is a viable approach
to quantify amyloid imaging data, without the need of arterial sampling or a reference region.
This technique can be a valuable tool for amyloid imaging, particularly in population where
reference normalization may not be accurate.
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Introduction
Alzheimer’s disease (AD) is the most common form of dementia [1]. Its prevalence is expected
to increase dramatically worldwide within the next 50 years as aging prevails across the globe
[2]. The future success of disease-modifying therapies will depend on accurate early diagnosis
of the disease before any clinical symptoms occur [3]. Although the underlying disease mecha-
nism is still unclear, AD is characterized by two pathological hallmarks: amyloid plaques, and
neurofibrillary tangles [1]. These pathological changes begin at least 10 to 20 years before clini-
cal symptoms appear [1,4–6]. Currently, there are no disease-modifying treatments available
[7], however, there is a growing consensus that effective treatment of AD may require early in-
tervention before the onset of clinical symptoms, and well validated surrogate biomarkers are
needed for the future treatment development and the design of therapy trials [8,9]. Among the
various biomarkers identified, positron emission tomography (PET) imaging of the beta-amy-
loid (Aβ) plaques with tracers such as [11C]PiB [10], [18F]florbetapir [11], [18F]florbetaben [12]
and [18F]flutemetamol[13], is the earliest indicator of AD pathology because they are capable
of in vivomeasurement of the amount of amyloid plaques in the brain. It is critical to quantify
Aβ burden accurately and robustly to further our understanding of disease mechanisms, to de-
velop early diagnostic techniques, and to identify suitable surrogate indicators for treatment
monitoring and efficacy evaluation.
With amyloid PET imaging, the amount of amyloid plaque in the brain is commonly as-
sessed based on some variant of a two-tissue compartment kinetic model [14,15]. In this model
(Fig 1), the PET tracer is assumed to present in three different forms, in the vasculature (vascu-
lature compartment), in the brain tissue as free or nonspecifically-bound tracer (nondisplace-
able compartment), and specifically bound tracer (specific compartment) [16]. The




¼ K1CP  ðk2 þ k3ÞCND þ k4CS ð1Þ
dCS
dt
¼ k3CND  k4CS ð2Þ
Fig 1. Illustration of two-tissue compartment model. Two of the compartments are located within the tissue: the nondisplaceable compartment containing
free plus nonspecifically bound tracer; and the specific compartment containing specifically bound tracer. (BBB: blood-brain barrier;CP, tracer concentration
within the vasculature compartment; CND, tracer concentration within the nondisplaceable compartment; Cs, tracer concentration within the specific
compartment; CT, tracer concentration in the tissue including both the nondisplaceable compartment and the specific compartment; K1, the influx rate
constant of tracer from the vasculature compartment to the tissue; k2, the washout rate constant of tracer from the tissue to the vasculature; k3, the rate
constant for tracer transfer from the nondisplaceable compartment to the specific compartment; k4, the rate constant for tracer transfer from specific
compartment to the nondisplaceable compartment.)
doi:10.1371/journal.pone.0122920.g001
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Where CP is the tracer concentration within the vasculature compartment, which is also com-
monly referred to as the arterial input function (AIF); CND is the tracer concentration within
the nondisplaceable compartment; Cs is the tracer concentration within the speciﬁc compart-
ment; and the kinetic rate constants K1-k4 describes the rate of tracer transfer among compart-
ments (Fig 1). With PET, the tracer concentration in the tissue as a function of time (CT) can
be directly measured. If the plasma concentration of the tracer (CP) is also known, then the ki-
netic rate constants K1-k4 can be determined via kinetic modeling [17]. The kinetic modeling is
commonly formulated as a non-linear least square ﬁt procedure that minimizes the difference
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After determination of kinetic rate constants, the binding potential (BPND = k3/k4) can be
calculated [16,17], which is of specific interest in amyloid PET imaging because it is propor-
tional to regional amyloid plaque density in the brain [16,19]. As we mentioned earlier, the ki-
netic modeling process requires the knowledge of CP. The conventional method to obtain AIF
is via an invasive arterial sampling procedure [14,15]. Aside from the invasive nature, this
method is also noisy and technically challenging [20,21]. To avoid arterial sampling, the cur-
rent standard amyloid imaging analysis uses a reference region based approach [14,19], where,
a reference region, normally cerebellar cortex, is assumed to be amyloid free and have the same
tracer influx to washout ratio as the target regions of interest. Regional binding potential can be
calculated by comparing region of interest PET signal against the reference region signal based
on some variation of the standard two-tissue compartment model [14,19]. In one implementa-
tion of the reference region based approach, a Logan graphical analysis model with reference

















Where, CR is the reference region tracer concentration; k2’ is the reference region washout rate
constant, and DVR is the distribution volume ratio and it is related to the rate constants and
binding potential as described in Eq 6, under the condition that K1/k2 = K1’/k2’ (K1’ is the refer-
ence region inﬂux rate constant) with no speciﬁc binding in the reference region.
DVR ¼ 1þ k3
k4
¼ 1þ BPND ð6Þ
Because of the fact that DVR is directly related to binding potential, it is also commonly
used as the outcome parameter in amyloid PET imaging quantiﬁcation [14,15]. Another com-
monly used reference region based imaging quantiﬁcation measurement is the standardized
uptake value ratio (SUVR) [24,25], which is simply the ratio of target region image intensity to
the reference region intensity. This measurement approximates DVR with the beneﬁts of
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requiring shorter scan time while introducing systematic biases [14,26]. While a cerebellar ref-
erence may be valid for many occasions, several conditions may make the assumption prob-
lematic [27], including prion disease [28,29] and familial AD [30], where amyloid deposition
also occurs in the cerebellar cortex, leading to the invalidity of the assumptions of the reference
region based technique. The observation of amyloid deposition in the cerebellar cortex of fa-
milial AD cases [31,32] prompted identiﬁcation and validation of pons as an alternative refer-
ence region [24]. For the same reason, in a recent study from the Dominantly Inherited
Alzheimer Network (DIAN), brain stem was used as the reference for quantiﬁcation [4]. Nev-
ertheless, in an earlier study that validated different amyloid imaging quantiﬁcation techniques,
an increase, although non-signiﬁcant, in tracer uptake for pons was observed in the AD group
[15]; in addition, in the study which validated pons as a reference region, an elevation in PiB re-
tention in pons was observed in an early onset AD patient albeit at a smaller level than cerebel-
lar cortex [24]. Therefore we cannot rule out the possibility of speciﬁc tracer uptake in the pons
in patients either. Moreover, any physiological/pathological changes in the region used as refer-
ence unrelated to amyloid deposition, such as stroke, infarct, or hemorrhage, will confound the
amyloid imaging quantiﬁcation by altering the delivery, transport and nonspeciﬁc binding of
the tracer, i.e. invalidates the assumption that K1/k2 = K1’/k2’.
Given the fact that reference region based techniques can be problematic in some patient
populations, we decided to investigate the feasibility of quantitative analysis techniques using
full kinetic modeling with AIF. As previously mentioned, the amount of amyloid deposited in
the brain can be directly estimated using kinetic modeling with the knowledge of AIF without a
reference region [16,17]. In fact, kinetic modeling with arterial sampling derived AIF was the
gold standard technique against which the reference region based approach was validated
[14,15,24]. However, conventional arterial sampling technique is invasive and challenging
[20,21]. On the other hand, a number of groups have investigated the possibility of deriving
AIF from imaging data without the need of arterial sampling [33–35]. Although this is an ap-
proach that has been studied for many years [34,36–40], a recent evaluation study of many of
these approaches suggested none of them could reliably estimate the AIF without arterial sam-
ples [33]. We believe the key reason for the failure of these methods is the fact that they are
solely dependent upon the PET data itself which does not have the spatial resolution needed to
identify pure vascular signal [33,38,41–43]. Recently, we developed an imaging-derived AIF
(IDAIF) technique that combines high resolution anatomical data with PET data, and demon-
strated its feasibility and robustness in the context of 15O-water PET studies [44]. Therefore,
the current goal is to adapt our IDAIF based technique for amyloid imaging to determine
whether quantification can be achieved without the need of a reference region or the invasive
arterial sampling procedure. We will use the IDAIF technique to quantify amyloid deposition
in a cohort of normal elderly and very mild AD patients, and compare the results with conven-
tional reference region based technique.
Methods
I. Participants
A total of 21 subjects were included in this study. They were all part of the Knight Alzheimer’s
Disease Research Center (ADRC) research participants enrolled in longitudinal studies of
memory and aging. Using a mean cortical binding potential (MCBP) cutoff of 0.18 as measured
by PiB PET imaging [19], 13 were considered PiB- (MCBP<0.18), the rest (N = 8) were PiB+
(MCBP>0.18). Four out of the eight participants in the PiB+ group had a CDR score of 0.5 or
greater. Demographic details are provided in Table 1. It should be pointed out that we specifi-
cally selected this population, where reference region based technique is considered valid
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[14,24], so that the proposed IDAIF technique can be tested against. In a future study, we will
further evaluate the proposed technique in populations where the reference region based ap-
proach is problematic.
I.1 Ethics Statement. All assessment and imaging procedures were approved by Washing-
ton University’s Human Research Protection Office, and written informed consent was ob-
tained from all individuals or their care-givers.
II. Imaging
PET imaging for amyloid deposition was performed using the radiotracer PiB. Preparation of
PiB was carried out based on existing protocol [45]. Dynamic PET imaging was conducted
with a Biograph 40 PET/CT scanner (Siemens Medical Solutions USA, Inc.) in three-dimen-
sional mode after intravenous administration of approximately 12mCi of PiB. The images were
reconstructed on a 128 x 128 x 109 matrix (2.32 x 2.32 x 2.03 mm) using filtered back-projec-
tion. Typical dynamic scans had 12 x 10-second frames, 3 x 1-minute frames, and 11 x 5-min-
ute frames. Anatomical MRI images were acquired with T1-weighted magnetization-prepared
rapid gradient echo (MPRAGE) sequence (TE = 3.16 msec, TI = 1000 msec, TR = 2400 msec)
using a Siemens Trio 3T scanner with1 mm isotropic voxels. Time-of-flight (TOF) MR angiog-
raphy (MRA) data was acquired (TE = 3.59 msec, TR = 23.0 msec, Flip = 18°) with 0.6 mm iso-
tropic voxels on the same scanner.
III. Image Analysis
The standard image analysis technique has been discussed previously [46] and a PET Unified
Pipeline (PUP) (https://github.com/ysu001/PUP) has been developed by our group to facilitate
automated PET data analysis. In summary, before PET data analysis using PUP, automatic
brain segmentation and parcellation of the MPRAGE data was performed using FreeSurfer
v5.1 (Martinos Center for Biomedical Imaging, Charlestown, Massachusetts, USA) for each
participant. In all datasets, visual inspection of the automated segmentation results was per-
formed for quality assurance purposes, and correction was done when necessary according to
the FreeSurfer manual. Using PUP, raw PET images were normalized to achieve a common
spatial resolution of 8mm to minimize scanner differences according to an established method
[47] as a part of our standard PET processing procedure. PET to MR and TOF-MRA to MR
registration were performed using a vector-gradient algorithm (VGM) [48]. Atlas registration
(12-parameter affine) was performed via the MPRAGE against a standard atlas template.
Inter-frame motion correction for the dynamic PET images was performed using standard
image registration techniques [49]. Regional time-activity curves for each ROI were extracted
by resampling the PET image to the MR space. Regional distribution volume ratio (DVRREF)
was estimated using Logan graphical analysis with cerebellar cortex as the reference [22]. The
linear fit in the Logan analysis was performed based on PET data between 30 to 60 minutes. A
Table 1. Demographics for this study.
Cohort PIB- PIB+
N 13 8
Age (SD) years 72.5(8.6) 75.4(6.6)
Education (SD) years 15.4(2.1) 16.7(3.5)
Male (%) 6(46.2) 6(75.0)
CDR>0 (%) 0(0.0) 4(50)
APOE4+ (%) 5(38.5) 5(62.5)
doi:10.1371/journal.pone.0122920.t001
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mean cortical DVR (MCDVR) was also calculated based on a selected set of cortical regions
[46]. The washout rate constant (k2’) of the reference region (cerebellar cortex) was set to 0.16/
minute. It has previously been shown that varying k2’ over a 10-fold range (0.05 to 0.5/minute)
has minimal impact on the DVR values [19].
IV. IDAIF Method
Similar to our previous work [44], a modified adaptive segmentation algorithm [50] is used to
automatically segment the MRA images to identify arteries (Fig 2). The arterial mask is
smoothed to PET resolution (8mm FWHM) and transferred to the MPRAGE space. A thresh-
old is automatically determined to obtain a 16 cc volume after thresholding the blurred arterial
mask within a rectangular box predefined in the atlas space centered at the petrous portion of
the internal carotid artery. This thresholded mask is used as the arterial ROI (ROIa) for AIF es-
timation (Fig 2). A lower threshold is also automatically determined to obtain a 100 cc volume
(ROIb) after thresholding the arterial mask, and the subtraction image of ROIa from ROIb was




¼ rCB þ sCBG ð7Þ
The variables r and s in Eq 7 are the recovery and spill over coefficients respectively to ac-
count for the limited spatial resolution of PET; CB is the whole blood activity concentration.
The AIF is derived based on fitting a kinetic model to the TAC of one large brain tissue ROI
(Ct), i.e. in our implementation the cerebellar cortex was used because it is the largest ROI gen-
erated by FreeSurfer segmentation although any large brain region can be used instead. In this
study, we combined two one-tissue compartmental models [16,17] to approximate the tracer
kinetics. The first one-tissue compartmental model (Eq 8) approximates the early kinetic be-
havior, i.e. before Ct peaks,
dCt
dt
¼ K1CP  k2Ct ð8Þ
Where, Ct is tissue time activity curve in the selected ROI; CP is the AIF; K1 and k2 are the inﬂux
and washout rate constant for the one-tissue compartment model. A second one-tissue com-
partmental model (Eq 9) approximates the two-tissue compartment kinetic behavior using a
one-tissue compartment model for late time points, i.e. after 40 minutes.
dCt
dt
¼ K1CP  k2aCt ð9Þ
where, k2a = k2/(1+k3/k4) [17]. This second one-tissue compartmental model has been pro-
posed and used widely in the simpliﬁed reference tissue model [51]. In this model, k2a is the ef-
fective washout rate constant; k2 is the washout rate constant for the two-tissue compartment
model, and k3 and k4 are the binding rate constants. For time in between, the kinetics is de-
scribed by a linear mixture of the two one-tissue compartmental models. For a given set of Ct,
Quantitative Amyloid Imaging Using Image-Derived Input Function
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where, w1 and w2 are weighting factors, with w1 linearly decreases from 1 to 0 and w2 increases
from 0 to 1.
To estimate AIF the following cost function is minimized by in a nonlinear least square
fashion:
QðK1; k2;K2a; sÞ ¼
XF
i¼1
½CPETROIaðiÞ  CMODROIa ðiÞ2 ð11Þ
where, i is the frame index, F is the total number of frames, CPETROIa refers to PET measured TAC
for ROIa, and CMODROIa refers to model estimated TAC for the arterial ROI (ROIa) as modeled ac-
cording to Eq 7. The recovery coefﬁcient r is determined based on the arterial ROI using a
8mm FWHMGaussian as the point spread function; s is estimated as one of the model param-
eters in Eq 11; CB is estimated based on the AIF (CP) by applying population average parent
compound ratio [14]. With two PET derived time activity curves from coregistered PET and
MR (Fig 2), i.e. CPETROIa and Ct, an optimal set of parameters (K1, k2, k2a, and s) are determined
that minimizes the cost Q, then AIF is calculated according to Eq 10.
V. Quantification using IDAIF
With AIF determined using the method described above, for each FreeSurfer region, regional


















Full kinetic modeling is then performed using the IDAIF according to the two-tissue com-
partment model (Eqs 1–4) [17]. In this work, independent model parameters K1, K1/k2, and k3
were directly estimated using nonlinear least square ﬁt; VT is kept ﬁxed using the value ob-
tained from Logan graphical analysis with arterial input. Distribution volume ratio DVRkinetic
was then calculated as VT/(K1/k2).
VI. Evaluation of the IDAIF technique
To demonstrate the validity of the IDAIF based technique for amyloid PET imaging quantifica-
tion, we analyzed the quantification results in the following three aspects: 1) we compared the
Fig 2. Three dimensional rendering of time-of-flight MRA (A), segmented arterial tree (B), the arterial region-of-interest (ROIa) (C), and one example
slice of the arterial ROI (ROIa) and the background region-of-interest (BG) (D). Example slice of coregistered MRI (E), MRA (F), PET(G), and ROIa (H).
doi:10.1371/journal.pone.0122920.g002
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estimated cerebellar cortex VT against literature reported values; 2) we examined whether DVR
calculated using the IDAIF technique was able to differentiate the PiB+ group from PiB- group
using two-tailed Welch’s t-test; 3) we compared the estimated DVR using the IDAIF technique
against reference region based DVR using both Pearson’s correlation (r) and intraclass correla-
tion (ICC) as the descriptive statistical parameters.
Results
An estimated AIF using the image based technique was demonstrated in Fig 3A, and an excel-
lent model fitting was achieved as shown in Fig 3B. Using IDAIF, estimated regional distribu-
tion volume (VT) was summarized in Table 2. The VT for cerebellar cortex for the PiB- group
was 3.20±0.47 with a 14.8% coefficient of variation. The mean value was in agreement with the
reported VT in control populations [15]. The variability of cerebellar VT was also in line with
previous studies [14,15,24]. The distribution of outcome measurements for the PiB- (N = 13)
and PiB+ (N = 8) groups were illustrated in Fig 4. All the outcome measurements, i.e. the
DVRs, were significantly different (p<0.01) between the two groups for caudate, precuneus,
gyrus rectus, lateral temporal, prefrontal, and mean cortical regions using two-tailed Welch’s t-
test. Also, as expected, the brain stem and cerebellar cortex do not show differences between
the two groups. The estimated regional DVR by full kinetic modeling using IDAIF (DVRkinetic)
was in excellent agreement (r = 0.8995, ICC = 0.8342) with the reference region based approach
(DVRREF) (Fig 5). The largest discrepancies between DVRkinetic (1.10) and DVRREF (1.35) was
18% which was primarily due to the differences in tracer delivery and nonspecific binding be-
tween the target region (K1/k2 = 3.07 for cortical mean) and reference region (VT = 2.51 for cer-
ebellar cortex).
Discussion
We developed and implemented a technique that estimates arterial input function from the
PET images with the help of coregistered TOF-MRA data. We evaluated this technique in the
context of amyloid PET imaging quantification and found excellent agreement between the
AIF and reference region based quantification. The evaluation was done in a cohort of normal
elderly and patients with very mild AD dementia where cerebellar cortex was a good reference
region with no specific uptakes as has been shown in previous studies [14,15]. Given the linear-
ized model for Logan graphical analysis with arterial input (Eq 12), a scaling of the AIF (CP)
would lead to an inversely scaled VT. A more than 2 fold larger VT was observed in Lopresti
et al. [14] when uncorrected carotid ROI TAC was used as the AIF. On the other hand, our esti-
mated VT using IDAIF was in line with literature reported values. In addition, our estimated
DVRkinetic using a kinetic modeling approach with IDAIF for individual regions without any
reference region was in good agreement with the reference region based DVRREF. These two
facts indicated our IDAIF was an accurate representation of real plasma arterial input to the
brain. We are currently pursuing a full validation study by comparing directly IDAIF based
amyloid imaging quantification against arterial sampling based quantification. Nevertheless,
the results presented in this study provided evidence that the IDAIF technique was a viable ap-
proach for amyloid imaging quantification without reference region.
It was observed that the variability of regional VT in the PiB- group (14.8%) was higher than
the DVRmeasurements (4.3% for DVRREF) (Table 2 and Fig 4) as observed previously [24].
Further investigation into this observation revealed a strong correlation between cerebellar cor-
tex VT and regional K1/k2 in the PiB- group (r = 0.969 for mean cortical ROI, r = 0.891 for cau-
date), suggesting the variation was largely due to factors that did not vary spatially. Therefore
the most likely source of variability in regional VT was either noise in the AIF, or variation in
Quantitative Amyloid Imaging Using Image-Derived Input Function
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Fig 3. Example cerebellar cortex TAC, arterial ROI TAC and estimated AIF (A); comparison of PETmeasured TAC andmodel estimated TAC for the
arterial ROI (B).
doi:10.1371/journal.pone.0122920.g003
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global perfusion, but not regional tracer delivery and transport. The fact that there is a similar
level of variability in cerebellar cortex VT in our study and previous studies [14,15,24] indicated
that the noise level in the IDAIF was comparable to arterial sampling based AIF. This variabili-
ty would be reduced by using a reference region based approach or full kinetic modeling since
the effect of K1 and k2 could be removed from such analyses. There was a similar level of vari-
ability in regional DVR between the two methods (DVRREF and DVRkinetic).
It should be pointed out that our proposed method used a population based parent com-
pound ratio for metabolites correction similar to what has been done by Lopresti et al. [14] in
their evaluation of image-derived AIF from carotid artery. One limitation of this approach is
the potential bias caused by individual variability of tracer metabolism. This limitation can be
avoided by performing metabolites analysis with venous samples, given the sparse sampling
typically performed for this type of analysis [14,15]. It should also be kept in mind that parent
compound ratio measurements can be noisy and may not be reliable on an individual basis.
As mentioned earlier, while using cerebellar cortex as the reference was the accepted stan-
dard for amyloid imaging quantification [14,15], in certain population such as familial AD
[30–32] and prion disease [28,29], amyloid plaque has been found in the cerebellum. Because
of this, Edison et al. (2012) specifically validated pons as an alternative reference. Based on re-
sults from our study, it could be seen that brain stem as defined in FreeSurfer which included
the pontine region could also serve as a reference region where no detectable difference in PiB
uptake between the PiB- and the PiB+ group. This supported the use of brain stem as the refer-
ence region in our previous [4,53] and ongoing studies of the DIAN cohort. Even within the
group examined in this study which did not have familial AD nor prion disease, the assump-
tion of comparable tracer delivery and nonspecific binding between the reference region and
target region did not always hold. For example, when mean cortical K1/k2 was compared to cer-
ebellum VT, there were three cases that had a difference greater than 15%. In the case with the
largest discrepancy (22%), it led to an 18% difference between DVR estimated with a reference
region (DVRREF) and a kinetic modeling approach (DVRkinetic) independent of reference re-
gion. Given the uncertainty in reference region validity and the effectiveness of estimating re-
gional DVR using IDAIF with kinetic modeling, quantification of amyloid PET imaging using
the proposed IDAIF technique would be beneficial not only in the population with suspected
cerebellum uptake, but also in sporadic AD population as well.
Table 2. Regional VT, regional DVR estimated using Logan analysis with cerebellar reference (DVRREF), and regionalDVR estimated with full kinet-
ic model (DVRkinetic).
Region logan VT DVRREF DVRkinetic
Mean±SD (CV%) Mean±SD (CV%) Mean±SD (CV%)
PiB- PiB+ PiB- PiB+ PiB- PiB+
Cerebellar Cortex 3.20±0.47 (14.8%) 3.21±0.61 (19.0%) 1 1 1.09±0.04 (3.7%) 1.10±0.03 (3.0%)
Brain Stem 4.41±0.70 (15.9%) 4.49±0.84 (18.8%) 1.37±0.06 (4.3%) 1.40±0.10 (6.9%) 1.30±0.11 (8.4%) 1.30±0.18 (14.2%)
Precuneus 3.60±0.51 (14.2%)* 5.50±1.86 (33.8%)* 1.12±0.05 (4.2%)* 1.66±0.28 (17.0%)* 1.18±0.05 (4.6%)* 1.54±0.23 (15.2%)*
Temporal 3.19±0.51 (15.9%) 4.46±1.60 (35.8%) 0.99±0.04 (4.3%)* 1.35±0.26 (19.1%)* 1.08±0.04 (3.6%)* 1.33±0.19 (14.5%)*
Prefrontal 3.15±0.51 (14.7%)* 4.93±1.51 (30.5%)* 0.98±0.04 (4.6%)* 1.50±0.21 (13.8%)* 1.18±0.06 (4.9%)* 1.56±0.17 (10.6%)*
Gyrus Recus 3.38±0.59 (17.3%)* 5.12±1.66 (32.5%)* 1.05±0.05 (5.1%)* 1.55±0.25 (15.8%)* 1.15±0.05 (4.0%)* 1.48±0.18 (11.9%)*
Caudate 3.23±0.50 (15.6%)* 4.25±1.17 (27.6%)* 1.00±0.05 (5.0%)* 1.30±0.16 (12.0%)* 1.28±0.06 (4.8%)* 1.51±0.18 (11.9%)*
MC 3.33±0.52 (15.7%)* 5.00±1.65 (32.9%)* 1.03±0.04 (3.8%)* 1.51±0.24 (15.9%)* 1.15±0.05 (4.0%)* 1.48±0.19 (12.5%)*
MC: the regions that went into the calculation of MCBP using a FreeSurfer based approach [46].
*Signiﬁcantly different between PiB- and PiB+ group (p<0.05).
doi:10.1371/journal.pone.0122920.t002
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Fig 4. Comparison of different outcomemeasurements between the PiB- (open downward triangles) and the PiB+ group (solid upward triangles)
for selected regions. CER: cerebellar cortex; BS: brain stem; CAU: caudate; PREC: precuneus; GR: gyrus rectus; TEMP: lateral temporal; PREF:
prefrontal; MC: mean cortical. VT: distribution volume; DVRREF: target-region-to-cerebellum distribution volume ratio estimated using Logan graphical analysis
with reference region (cerebellar cortex); DVRkinetic: VT/(K1/k2) estimated using full kinetic modeling with IDAIF.
doi:10.1371/journal.pone.0122920.g004
Quantitative Amyloid Imaging Using Image-Derived Input Function
PLOS ONE | DOI:10.1371/journal.pone.0122920 April 7, 2015 12 / 16
Conclusion
An image-based method to derive arterial input function was developed and evaluated in the
context of amyloid PET imaging quantification. Excellent agreement in distribution volume
measurements was observed between the IDAIF technique and the reference region based
method. This demonstrates the IDAIF technique was a viable approach to quantify amyloid
imaging data to eliminate the need of arterial sampling or a reference region. Further investiga-
tion is ongoing to apply this technique in population with suspected specific uptake of PiB in
proposed reference tissue and to provide full validation with arterial sampling data.
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